Horiba UK (Northampton, UK) has joined the Lifetime Centre for Doctoral Training (CDT, Birmingham, UK) as an industry partner. The goal of the partnership is to provide a new generation of scientists with skills and approaches designed to reduce and replace the need for animal testing in the fields of drug discovery, toxicology screening, and regenerative medicine.
The Lifetime (Engineered Tissues for Discovery, Industry and Medicine) CDT is a partnership between the University of Glasgow (Glasgow, Scotland), the University of Birmingham (Birmingham, New York), Aston University (Birmingham, UK), and CÚRAM – Science Foundation Ireland at the National University of Ireland, Galway. The CDT’s focus is on high-value skills training across a range of scientific disciplines to enable research students to develop non-animal technologies (NATs) that better mimic physiology and disease.
In partnership with industry, the Lifetime CDT uses knowledge-exchange and co-creation in pioneering science to develop bioengineered humanized 3D models, microfluidics, diagnostics, and sensing platforms. As an industry partner, Horiba will co-create, support, and mentor a four-year research project to explore how spectroscopy can help drive new methods of cell screening and disease diagnosis based on animal-free research.
New SERS-Microfluidic Platform Classifies Leukemia Using Machine Learning
January 14th 2025A combination of surface-enhanced Raman spectroscopy (SERS) and machine learning on microfluidic chips has achieved an impressive 98.6% accuracy in classifying leukemia cell subtypes, offering a fast, highly sensitive tool for clinical diagnosis.
Advancing Soil Carbon Analysis Post-Wildfire with Spectroscopy and Machine Learning
January 14th 2025Researchers from the University of Oviedo used diffuse reflectance spectroscopy (DRS) and machine learning (ML) to analyze post-wildfire soil organic carbon fractions, identifying key spectral regions and algorithms for advancing remote sensing applications.
Oligonucleotide Analysis in Pharmaceutical Quality Control
January 14th 2025Melting point determination using ultraviolet-visible (UV-Vis) spectrophotometry can be used as a sequence-specific method for identifying therapeutic oligonucleotides in pharmaceutical quality control. This method offers a simple, highly selective approach to differentiate between isomers and ensure the integrity of oligonucleotide active pharmaceutical ingredients (APIs) and drug products.
The Optical Properties of Solid Samples
January 14th 2025Transmittance and reflectance measurements, which are useful for estimating the effects of various physical processes, can include thermal treatments, ionizing radiation exposure, optical exposure, and mechanical treatments—on both crystals and thin films.